Contract W81XWH13P0260
Asuragen Incorporated · Department Of Defense · May 13, 2013
Asuragen Incorporated was awarded a federal contract by Department Of Defense (Department Of The Army) on May 13, 2013 for $74,000 of work in research and development in biotechnology. Performance is in Silver Spring, MD. It was awarded under a small business set-aside. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 13, 2017.
Contract details
- PIID
- W81XWH13P0260
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Support- Professional: Other
- Place of performance
- Silver Spring, MD
- First action
- May 13, 2013
- Latest action
- September 13, 2017
Description
IGF::CT::IGF MICROARRAY SERVICES
Modification timeline
-
September 13, 2017Mod P00003$-30.3K
-
June 13, 2014Mod P00002MICROARRAY SERVICES$0
-
August 26, 2013Mod P00001MICROARRAY SERVICES$0
-
May 13, 2013Base awardMICROARRAY SERVICES$104.4K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $0 |
| Bluehalo, Llc | Department Of Defense | November 4, 2025 | $3.00M |
| Inbios International Inc | Department Of Defense | September 22, 2025 | $25.66M |
| Dynport Vaccine Company Llc | Department Of Defense | September 12, 2025 | $117.63M |
| Westat, Inc. | Department Of Defense | August 28, 2025 | $22.21M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81XWH13P0260?
Contract W81XWH13P0260 is a federal contract awarded to Asuragen Incorporated by Department Of Defense on May 13, 2013 for $74,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 3 times since the base award.
Who won contract W81XWH13P0260?
Asuragen Incorporated won contract W81XWH13P0260 from Department Of Defense.
How much is contract W81XWH13P0260 worth?
Contract W81XWH13P0260 has obligated $74,000 to date.